Plastod
Plastod is a company with over 100 years of experience in advanced wound care solutions. It specializes in the design, development, and manufacturing of innovative medical dressings, including advanced wound dressings, with a focus on quality, safety, and technological innovation. Plastod collaborates with leading medical companies worldwide and is committed to improving patients' quality of life through tailored solutions and sustainable practices.
Industries
Nr. of Employees
medium (51-250)
Plastod
Via W. Masetti, 7, 40012 Calderara di Reno, Bologna, Italy
Products
Foam dressings (bordered and shaped)
Sterile hydrophilic foam dressings available in multiple formats and anatomical shapes (bordered sacral shape, heel shape, tracheal shape, toe caps, pattern-bordered designs) and non-adhesive foam pads. Variants include adhesive-bordered and non-adhesive pads requiring secondary fixation; intended to manage moderate-to-heavy exudate, prevent maceration and maintain a moist healing environment.
Silicone foam dressings
Breathable, absorbent silicone foam dressings designed for gentle adhesion and management of exuding wounds, intended for fragile or sensitive skin.
PHMB foam dressings
Foam dressings incorporating polyhexamethylene biguanide for sustained antimicrobial action to reduce bacterial colonization in infected or at-risk wounds.
Alginate dressings and alginate rope
Dressings and ropes made from biodegradable alginate fibers that form a gel on contact with exudate to promote moist wound healing and atraumatic removal; rope variant for cavity applications.
Hydrocolloid dressings
Hydrocolloid dressings designed to maintain optimal moisture, support autolytic debridement and protect wounds from external contamination for acute and chronic wounds.
Hydrofiber dressings
Hydrofiber dressings that form a soft gel on contact with wound fluids, offering effective exudate management and reduced maceration risk for heavily exuding wounds.
Foam dressings (bordered and shaped)
Sterile hydrophilic foam dressings available in multiple formats and anatomical shapes (bordered sacral shape, heel shape, tracheal shape, toe caps, pattern-bordered designs) and non-adhesive foam pads. Variants include adhesive-bordered and non-adhesive pads requiring secondary fixation; intended to manage moderate-to-heavy exudate, prevent maceration and maintain a moist healing environment.
Silicone foam dressings
Breathable, absorbent silicone foam dressings designed for gentle adhesion and management of exuding wounds, intended for fragile or sensitive skin.
PHMB foam dressings
Foam dressings incorporating polyhexamethylene biguanide for sustained antimicrobial action to reduce bacterial colonization in infected or at-risk wounds.
Alginate dressings and alginate rope
Dressings and ropes made from biodegradable alginate fibers that form a gel on contact with exudate to promote moist wound healing and atraumatic removal; rope variant for cavity applications.
Hydrocolloid dressings
Hydrocolloid dressings designed to maintain optimal moisture, support autolytic debridement and protect wounds from external contamination for acute and chronic wounds.
Hydrofiber dressings
Hydrofiber dressings that form a soft gel on contact with wound fluids, offering effective exudate management and reduced maceration risk for heavily exuding wounds.
Services
Technical product development services from concept definition and feasibility through prototyping and pilot production for wound care devices.
Prototype validation and formal design freeze to lock device specifications, materials and dimensions for stable production.
Optimization and automation of manufacturing processes to transition products from pilot to large-scale production, including custom machinery implementation.
Regulatory assistance covering EU MDR compliance, CE marking migration, post-market requirements and product monitoring.
Batch-level machine and quality tests, material and product monitoring using on-site analytical lab capabilities and accredited external labs for complex testing.
Technical product development services from concept definition and feasibility through prototyping and pilot production for wound care devices.
Prototype validation and formal design freeze to lock device specifications, materials and dimensions for stable production.
Optimization and automation of manufacturing processes to transition products from pilot to large-scale production, including custom machinery implementation.
Regulatory assistance covering EU MDR compliance, CE marking migration, post-market requirements and product monitoring.
Batch-level machine and quality tests, material and product monitoring using on-site analytical lab capabilities and accredited external labs for complex testing.
Expertise Areas
- Advanced wound care product development
- Contract manufacturing and co-development for medical devices
- Regulatory compliance for medical devices (EU MDR, CE marking, ISO 9001, ISO 13485)
- Sterile manufacturing and sterilization processes
Key Technologies
- Cleanroom manufacturing (ISO 8)
- Sterilization: irradiation
- Sterilization: ethylene oxide
- High-speed rotary and automated converting machinery
News & Updates
Plastod will participate in the 35th EWMA-GNEAUPP congress in Barcelona from March 26-28, 2025, showcasing innovative solutions for wound care.
Plastod will exhibit at MEDICA 2024 in Düsseldorf, Germany, from November 11-14, 2024, at Stand B16, Hall 6.
Participation in EWMA 2024 congress in London, May 1-3, 2024, with a focus on wound management innovations.
Plastod successfully migrated CE marking for all medical devices in compliance with the new European MDR regulation.
Plastod will participate in the 35th EWMA-GNEAUPP congress in Barcelona from March 26-28, 2025, showcasing innovative solutions for wound care.
Plastod will exhibit at MEDICA 2024 in Düsseldorf, Germany, from November 11-14, 2024, at Stand B16, Hall 6.
Participation in EWMA 2024 congress in London, May 1-3, 2024, with a focus on wound management innovations.
Plastod successfully migrated CE marking for all medical devices in compliance with the new European MDR regulation.